Lp-PLA2: an emerging biomarker of coronary heart disease.
作者： Nisha Dada , Nam W Kim , Robert L Wolfert
关键词: Proinflammatory cytokine 、 Lipoprotein 、 Disease 、 Cause of death 、 Biomarker (medicine) 、 Internal medicine 、 Inflammation 、 1-Alkyl-2-acetylglycerophosphocholine Esterase 、 Cardiology 、 Medicine 、 Phospholipase A2
摘要: … evidence supporting the view that Lp-PLA 2 is a potential … Lp-PLA 2 mass in human plasma developed by diaDexus, Inc. is presented. Furthermore, potential clinical applications of Lp…
informahealthcare.com参考文章(43)
Christopher K. Glass, Joseph L. Witztum, Atherosclerosis: The Road Ahead Cell. ,vol. 104, pp. 503- 516 ,(2001) , 10.1016/S0092-8674(01)00238-0
Pamela A. Sytkowski, William B. Kannel, Ralph B. D'Agostino, Changes in Risk Factors and the Decline in Mortality from Cardiovascular Disease New England Journal of Medicine. ,vol. 322, pp. 1635- 1641 ,(1990) , 10.1056/NEJM199006073222304
Tetsuya Kosaka, Masahiro Yamaguchi, Yasuji Soda, Tatsuya Kishimoto, Akio Tago, Mitsuyoshi Toyosato, Koji Mizuno, Spectrophotometric assay for serum platelet-activating factor acetylhydrolase activity Clinica Chimica Acta. ,vol. 296, pp. 151- 161 ,(2000) , 10.1016/S0009-8981(00)00216-3
Keri L.H. Carpenter, Ian F. Dennis, Iain R. Challis, David P. Osborn, Colin H. Macphee, David S. Leake, Mark J. Arends, Malcolm J. Mitchinson, Inhibition of lipoprotein-associated phospholipase A2 diminishes the death-inducing effects of oxidised LDL on human monocyte-macrophages. FEBS Letters. ,vol. 505, pp. 357- 363 ,(2001) , 10.1016/S0014-5793(01)02840-X
M.J. Caslake, D.S.J. O'Reilly, C.J. Packard, A. Rumley, J. Cooney, G.D.O. Lowe, A.D. McMahon, M. Krishna, K.E. Suckling, I. Ford, F.E. Wilkinson, C.H. Macphee, Lipoprotein-associated phospholipase A(2) as an independent predictor of coronary heart disease Massachusetts Medical Society. ,(2000)
R.Y. Ball, E.C. Stowers, J.H. Burton, N.R.B. Cary, J.N. Skepper, M.J. Mitchinson, Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. Atherosclerosis. ,vol. 114, pp. 45- 54 ,(1995) , 10.1016/0021-9150(94)05463-S
C Macphee, Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target. Current Opinion in Pharmacology. ,vol. 1, pp. 121- 125 ,(2001) , 10.1016/S1471-4892(01)00024-8
P. Spangenberg, Ch. Schymik, B. Hofmann, G. Ostermann, K. Rühling, U. Till, Blood platelet behaviour in patients with a type I diabetes mellitus. Experimental and Clinical Endocrinology & Diabetes. ,vol. 94, pp. 329- 337 ,(2009) , 10.1055/S-0029-1210918
Yoshiji Yamada, Hidemi Yoshida, Sahoko Ichihara, Tadaatsu Imaizumi, Kei Satoh, Mitsuhiro Yokota, Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population Atherosclerosis. ,vol. 150, pp. 209- 216 ,(2000) , 10.1016/S0021-9150(99)00385-8
Diana M. Stafforini, Thomas M. McIntyre, Guy A. Zimmerman, Stephen M. Prescott, Platelet-activating factor acetylhydrolases. Journal of Biological Chemistry. ,vol. 272, pp. 17895- 17898 ,(1997) , 10.1074/JBC.272.29.17895